Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The injectable formulations are administered once weekly via subcutaneous injection, meaning the medication is delivered into the fatty tissue layer beneath the skin rather than into muscle or directly into the bloodstream
Ann Diagn Pathol (2003) 7(4):2548
This gradual approach minimizes gastrointestinal side effects and allows patients to adjust to the medication
Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy
needle-free alternative for patients who prefer to avoid injections Compounded Tirzepatide (injectable) weekly dual GLP-1/GIP receptor agonist Liraglutide daily injectable GLP-1
US$ 28.57
US$ 27.42
US$ 23.34
US$ 27.28
US$ 22.97
